Table 4. Predictive factors for OS using univariate and multivariate analyses of the cohort (n=90).
Factors | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Gender | ||||||
Female | 1 | - | ||||
Male | 1.58 | 0.82–3.04 | 0.17 | - | - | - |
Tumor location | ||||||
Rectum | 1 | - | ||||
Colon | 0.58 | 0.11–1.13 | 0.11 | - | - | - |
Histologic types | ||||||
MAC | 1 | - | ||||
SRC | 1.97 | 0.96–4.06 | 0.064 | - | - | - |
Adjuvant CT | ||||||
No | 1 | 1 | ||||
Yes | 0.20 | 0.083–0.50 | 0.001 | 0.96 | 0.29–3.21 | 0.95 |
Cycles of adjuvant CT | ||||||
<6 | 1 | 1 | ||||
≥6 | 0.36 | 0.17–0.76 | 0.007 | 0.21 | 0.083–0.57 | 0.002 |
Tumor size, cm | ||||||
<5 | 1 | - | ||||
≥5 | 1.42 | 0.91–2.23 | 0.13 | - | - | - |
Surgical types | ||||||
Radical | 1 | 1 | ||||
Palliative | 3.90 | 2.03–7.52 | <0.001 | 1.67 | 0.43–6.49 | 0.46 |
T stage | ||||||
T2 | 1 | |||||
T3 | 1.55 | 0.20–12.13 | 0.67 | - | - | - |
T4 | 3.93 | 0.52–29.52 | 0.18 | - | - | - |
N stage | ||||||
N0 | 1 | 1 | ||||
N1 | 2.16 | 0.77–6.08 | 0.144 | - | - | - |
N2 | 2.89 | 1.07–7.76 | 0.035 | - | - | - |
Metastasis | ||||||
No | 1 | 1 | ||||
Yes | 4.39 | 2.24–8.59 | <0.001 | 1.05 | 0.18–5.95 | 0.95 |
Stage | ||||||
I/II | 1 | 1 | ||||
III/IV | 3.25 | 1.83–5.80 | <0.001 | 1.57 | 0.53–4.69 | 0.42 |
Preoperative CEA levels, U/ml | ||||||
<3.7 | 1 | 1 | ||||
≥3.7 | 3.77 | 1.91–7.43 | <0.001 | 2.43 | 1.13–5.62 | 0.024 |
Lymphovascular invasion | ||||||
Negative | 1 | 1 | ||||
Positive | 3.00 | 1.52–5.39 | 0.002 | 1.36 | 0.53–3.47 | 0.52 |
Perineural invasion | ||||||
Negative | 1 | 1 | ||||
Positive | 1.85 | 0.96–3.57 | 0.065 | 1.28 | 0.59–2.79 | 0.53 |